These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22947344)

  • 1. Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis.
    Novak N; Bieber T; Hoffmann M; Fölster-Holst R; Homey B; Werfel T; Sager A; Zuberbier T
    J Allergy Clin Immunol; 2012 Oct; 130(4):925-31.e4. PubMed ID: 22947344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
    Bussmann C; Maintz L; Hart J; Allam JP; Vrtala S; Chen KW; Bieber T; Thomas WR; Valenta R; Zuberbier T; Sager A; Novak N
    Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study.
    Pajno GB; Caminiti L; Vita D; Barberio G; Salzano G; Lombardo F; Canonica GW; Passalacqua G
    J Allergy Clin Immunol; 2007 Jul; 120(1):164-70. PubMed ID: 17543376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
    Silny W; Czarnecka-Operacz M
    Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study.
    Cadario G; Galluccio AG; Pezza M; Appino A; Milani M; Pecora S; Mastrandrea F
    Curr Med Res Opin; 2007 Oct; 23(10):2503-6. PubMed ID: 17784996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of atopic dermatitis with a combination of allergen-specific immunotherapy and a histamine-immunoglobulin complex.
    Nahm DH; Lee ES; Park HJ; Kim HA; Choi GS; Jeon SY
    Int Arch Allergy Immunol; 2008; 146(3):235-40. PubMed ID: 18268392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study.
    Werfel T; Breuer K; Ruéff F; Przybilla B; Worm M; Grewe M; Ruzicka T; Brehler R; Wolf H; Schnitker J; Kapp A
    Allergy; 2006 Feb; 61(2):202-5. PubMed ID: 16409197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of immunotherapy in patients with rhinitis, asthma or atopic dermatitis using an ultra-rush buildup. A retrospective study.
    Cardona R; Lopez E; Beltrán J; Sánchez J
    Allergol Immunopathol (Madr); 2014; 42(2):90-5. PubMed ID: 23265265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
    Wang HY; Lin XP; Hao CL; Zhang CQ; Sun BQ; Zheng JP; Chen P; Sheng JY; Wu A; Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis?
    Bussmann C; Böckenhoff A; Henke H; Werfel T; Novak N
    J Allergy Clin Immunol; 2006 Dec; 118(6):1292-8. PubMed ID: 17157659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Efficacy of Subcutaneous Allergen Immunotherapy in Patients with Atopic Dermatitis.
    Nahm DH; Kim ME; Kwon B; Cho SM; Ahn A
    Yonsei Med J; 2016 Nov; 57(6):1420-6. PubMed ID: 27593870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind placebo-controlled house dust mite control measures in adult patients with atopic dermatitis.
    Gutgesell C; Heise S; Seubert S; Seubert A; Domhof S; Brunner E; Neumann C
    Br J Dermatol; 2001 Jul; 145(1):70-4. PubMed ID: 11453909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of House Dust Mite Sublingual Immunotherapy in Patients with Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Langer SS; Cardili RN; Melo JML; Ferriani MPL; Moreno AS; Dias MM; Bueno-Filho R; Pocente RHC; Roxo-Junior P; Silva J; Valera FCP; Coelho EB; Galvão CES; Carmona F; Aragon DC; Arruda LK
    J Allergy Clin Immunol Pract; 2022 Feb; 10(2):539-549.e7. PubMed ID: 34767999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
    Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
    Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous immunotherapy with a depigmented polymerized birch pollen extract--a new therapeutic option for patients with atopic dermatitis.
    Novak N; Thaci D; Hoffmann M; Fölster-Holst R; Biedermann T; Homey B; Schaekel K; Stefan JA; Werfel T; Bieber T; Sager A; Zuberbier T
    Int Arch Allergy Immunol; 2011; 155(3):252-6. PubMed ID: 21293143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synbiotics could not reduce the scoring of childhood atopic dermatitis (SCORAD): a randomized double blind placebo-controlled trial.
    Shafiei A; Moin M; Pourpak Z; Gharagozlou M; Aghamohammadi A; Sajedi V; soheili H; Sotoodeh S; Movahedi M
    Iran J Allergy Asthma Immunol; 2011 Mar; 10(1):21-8. PubMed ID: 21358011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sublingual immunotherapy of atopic dermatitis in mite-sensitized patients: a multi-centre, randomized, double-blind, placebo-controlled study.
    Liu L; Chen J; Xu J; Yang Q; Gu C; Ni C; Li L; Lu X; Yao Z; Tao J; Guo Y; Fang H; Ding Y; Qian Q; Zhou N; Wang M; Deng D; Xie H; Li S; Huang Y; Zhao N; Zheng M
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3540-3547. PubMed ID: 31437010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double-blind, placebo-controlled study.
    Hon KL; Leung TF; Ng PC; Lam MC; Kam WY; Wong KY; Lee KC; Sung YT; Cheng KF; Fok TF; Fung KP; Leung PC
    Br J Dermatol; 2007 Aug; 157(2):357-63. PubMed ID: 17501956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: first results of ETAC. Early Treatment of the Atopic Child.
    Pediatr Allergy Immunol; 1998 Aug; 9(3):116-24. PubMed ID: 9814724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of desensitization using household dust mite in patients with atopic dermatitis].
    Samochocki Z; Rudzki E
    Przegl Dermatol; 1990; 77(2):132-6. PubMed ID: 2217840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.